Renalytix Revenue and Competitors
Estimated Revenue & Valuation
- Renalytix's estimated annual revenue is currently $14.9M per year.
- Renalytix's estimated revenue per employee is $155,000
Employee Data
- Renalytix has 96 Employees.
- Renalytix grew their employee count by 0% last year.
Renalytix's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | VP Sales | Reveal Email/Phone |
3 | Director, Sales Operations & Analytics | Reveal Email/Phone |
4 | Director, Quality System Compliance and EH&S | Reveal Email/Phone |
5 | Product Manager, Digital Health Solutions | Reveal Email/Phone |
6 | Product Manager, Digital Health Solutions | Reveal Email/Phone |
7 | Kidney Health Account Executive | Reveal Email/Phone |
8 | Kidney Health Account Executive, Government Accounts | Reveal Email/Phone |
9 | Kidney Health Specialist | Reveal Email/Phone |
10 | Clinical Laboratory Scientist (CLS) | Reveal Email/Phone |
Renalytix Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $20.5M | 132 | 8% | $1.4B | N/A |
What Is Renalytix?
N/A
Total Funding
96
Number of Employees
$14.9M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Renalytix News
2022-03-30 - Renalytix announces a $30.0 million financing package
Renalytix (LSE: RENX) (NASDAQ: RNLX) is the global founder and leader in the new field of bioprognosis for kidney health. The company has...
2022-03-30 - Renalytix Reaches Enrollment Milestone for Building ...
Renalytix Reaches Enrollment Milestone for Building KidneyIntelX as Premier Precision Medicine Platform for Kidney Disease and Diabetes.
2022-03-30 - Renalytix Reports Financial Results for Second Quarter of ...
and Renalytix AI Limited (collectively, Renalytix, or the Company) is an artificial intelligence-enabled in vitro diagnostics company...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $25.9M | 96 | 0% | N/A |
#2 | N/A | 96 | 2% | N/A |
#3 | $4.8M | 96 | -5% | N/A |
#4 | $8.6M | 96 | 37% | N/A |
#5 | $15.6M | 96 | 9% | N/A |